Tashin Pharmaceutical Reports Zero Revenue for April 2026
Tashin Pharmaceutical reported zero revenue for April 2026. The company, operating in the biotechnology and medical industry, generated no income during the month, with no year-over-year comparison available.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 09:00
- 🔍 Collected: May 12, 2026 at 08:00 (983h 0m after Published)
- 🤖 AI Analyzed: May 12, 2026 at 09:26 (1h 26m after Collected)
Tashin Pharmaceutical (Stock Code: 6838), a company in the biotechnology and medical industry, announced its revenue for April 2026. The company generated NT$0 thousand (NT$0.00 million) in revenue for the month. No year-over-year comparison data was provided.